World Of Taxonomy
C160525Level 4

Bevacizumab/Liposomal Doxorubicin Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bevacizumab and liposomal doxorubicin that can be used for the treatment of ovarian, fallopian tube, and primary peritoneal cancers.

**Synonyms:** - Avastin/Doxil - Bevacizumab-Liposomal Doxorubicin - Bevacizumab/Liposomal Doxorubicin - Bevacizumab/Pegylated Liposomal Doxorubicin - Doxil/Avastin - Liposomal Doxorubicin/Bevacizumab Regimen - Non-pegylated liposomal doxorubicin and Bevacizumab-tnjn - Pegylated Liposomal Doxorubicin/Bevacizumab - Pegylated liposomal doxorubicin and Bevacizumab - Pegylated liposomal doxorubicin and Bevacizumab-adcd - Pegylated liposomal doxorubicin and Bevacizumab-awwb - Pegylated liposomal doxorubicin and Bevacizumab-aybi - Pegylated liposomal doxorubicin and Bevacizumab-bvzr - Pegylated liposomal doxorubicin and Bevacizumab-equi - Pegylated liposomal doxorubicin and Bevacizumab-maly - Pegylated liposomal doxorubicin and Bevacizumab-onbe - Pegylated liposomal doxorubicin and Bevacizumab-tnjn

GET/api/v1/systems/nci_thesaurus/nodes/C160525
Official DownloadCC BY 4.0Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.